IP Library Granted Patent US 8,314,248
Granted Patent B2
US 8,314,248 · App. 13/308,046 · Granted Nov 20, 2012

Process for preparing epothilone derivatives by selective catalytic epoxidation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,314,248
App. No.
13/308,046
Granted
Nov 20, 2012
Kind
B2
Abstract

The present invention describes a novel process for preparing an epothilone derivative using substituted pyridines and methyltrioxorhenium as catalyst.

Claims (15)

1. A process for preparing the epothilone derivative of the formula (I)

comprising epoxidizing a dialkene of formula (II)

using methyltrioxorhenium with an epoxidizing agent in an aprotic solvent at −60° C. to −20° C.

2. The process according to claim 1 , in which the epoxidizing agent is aqueous hydrogen peroxide solution.

3. The process according to claim 1 , further comprising adding of a substituted pyridine derivative.

4. The process according to claim 3 , comprising reacting the dialkene of formula (II) at −60 to −20° C. in chlorinated hydrocarbons or mixtures thereof with low-boiling alkanes or toluene or trifluorotoluene as solvent

using 6-36 mol % of a substituted pyridine,

and 1-7 mol % methyltrioxorhenium

and 2-5 equivalents of 10-60% strength aqueous hydrogen peroxide solution.

5. The process according to claim 1 , where the reaction times are between 20-120 h.

6. The process according to claim 1 , where the concentration of the compound of the formula II is in the range from 1 g in 5 ml of solvent to 1 g in 50 ml of solvent.

7. The process according to claim 1 , wherein the solvent is dichloromethane, 1,2-dichloroethane, chloroform, or mixtures thereof with pentane, hexane, heptane, cyclohexane, toluene or trifluorotoluene, or toluene or trifluorotoluene alone.

8. The process according to claim 3 , wherein the substituted pyridine is

9. The process according to claim 3 , wherein the substituted pyridine is an electron-poor pyridine compound which is substituted in position 4 by CN, Br, Cl, F, CF 3 , SO 2 (C 1 -C 4 )alkyl, SO 2 NH 2 , SO 2 N[(C 1 -C 4 )alkyl] 2 , COOH or COO(C 1 -C 4 )alkyl.

10. The process according to claim 1 , wherein the crude product obtained is crystallized.

Assignments (2)
CHANGE OF NAME Recorded Jul 1, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030719/0474 →
CHANGE OF NAME Recorded Nov 11, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 029277/0286 →